Clinical Trial Update: A Retrospective Chart Review Study of the Outcomes of 2nd Line Therapy With LEn/Dex in Greek Patients With R/R Multiple MyEloma and the Treatment PatterNs Following Progressive Disease

View source ↗

Summary

This clinical trial update reports results from a retrospective chart review of second-line lenalidomide/dexamethasone therapy and treatment patterns after prog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Revlimid (lenalidomide)

Snippet

Sponsor: Genesis Pharma S.A. | Conditions: Relapsed/Refractory Multiple Myeloma | Status: COMPLETED